Physician

Tyler Looysen, MD, MPH

According to 2025 Medicare claims, Tyler Looysen, MD, MPH (NPI: 1134614381) practices ophthalmology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is RETINA CONSULTANTS, LTD (NPI: 1972589182; TIN: 450408552) and primary practice location at 58104-4556.

Looysen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 24,959 HCPCS/CPT codes, and received $992,450 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 234 prescription claims across 98 beneficiaries totaling $7,037 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $104. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$496K$992K2023 Medicare payment: $4,472 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $992,450 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20232945$4,472
202450824,959$992,450

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$23K$46K2018 Drug cost: $5,234 (USD; Tot_Drug_Cst)2019 Drug cost: $10,289 (USD; Tot_Drug_Cst)2020 Drug cost: $22,124 (USD; Tot_Drug_Cst)2021 Drug cost: $45,631 (USD; Tot_Drug_Cst)2022 Drug cost: $23,075 (USD; Tot_Drug_Cst)2023 Drug cost: $11,173 (USD; Tot_Drug_Cst)2024 Drug cost: $7,037 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182990$5,234
2019110214$10,289
2020147317$22,124
2021139459$45,631
2022131444$23,075
2023117296$11,173
202498234$7,037

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system145145$97
67028Injection of drug into eye304573$96
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more159221$70
92134Imaging of retina481787$31
J2777Injection, faricimab-svoa, 0.1 mg16221,120$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate691,812$2,677
OfloxacinOfloxacin38856$506
Ketorolac TromethamineKetorolac Tromethamine27878$464
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat13550$345
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha23453$336

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$104EyePoint Pharmaceuticals US, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tyler Looysen, MD, MPH?

Tedicare shows public-source Medicare data for Tyler Looysen, MD, MPH (NPI 1134614381), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tyler Looysen, MD, MPH have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tyler Looysen, MD, MPH?

Tyler Looysen, MD, MPH is linked to RETINA CONSULTANTS, LTD (billing NPI 1972589182) in the available physician profile data.

Does Tyler Looysen, MD, MPH have Open Payments data?

Tyler Looysen, MD, MPH has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.